Literature DB >> 11006289

Active DNA topoisomerase IIalpha is a component of the salt-stable centrosome core.

H U Barthelmes1, P Grue, S Feineis, T Straub, F Boege.   

Abstract

Recently, we reported that the monoclonal antibody specific for human DNA topoisomerase IIalpha, Ki-S1, stains not only the nuclei of human A431 cells but also extranuclear structures suggestive of centrosomes (Meyer, K. N., Kjeldsen, E., Straub, T., Knudsen, B. K., Kikuchi, A., Hickson, I. D., Kreipe, H., and Boege, F. (1997) J. Cell Biol. 136, 775-788). Here, we confirm colocalization of Ki-S1 with the centrosomal marker gamma-tubulin. In addition, we show labeling of centrosomes by peptide antibodies against the N and C termini of human topoisomerase IIalpha. Probing Western blots of isolated centrosomes with topoisomerase IIalpha antibodies, we demonstrate a protein band of 170 kDa. Moreover, isolated centrosomes exhibited DNA decatenation and relaxation activity correlated to the amount of topoisomerase IIalpha protein in the same way as seen in the pure recombinant enzyme. Topoisomerase IIalpha epitopes could not be removed from centrosomes by salt extraction, DNase treatment, or RNase treatment, procedures that completely removed the enzyme from nuclei. Taken together, these observations suggest that active topoisomerase IIalpha is bound tightly to the centrosome in a DNA-independent manner. Because such centrosomal topoisomerase IIalpha was also present in quiescent lymphocytes devoid of topoisomerase IIalpha in the nuclei, we assume that it might be a long-lived storage form.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11006289     DOI: 10.1074/jbc.M007044200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Contribution of hCAP-D2, a non-SMC subunit of condensin I, to chromosome and chromosomal protein dynamics during mitosis.

Authors:  Erwan Watrin; Vincent Legagneux
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

Review 2.  Repair of topoisomerase I-mediated DNA damage.

Authors:  Yves Pommier; Juana M Barcelo; V Ashutosh Rao; Olivier Sordet; Andrew G Jobson; Laurent Thibaut; Ze-Hong Miao; Jennifer A Seiler; Hongliang Zhang; Christophe Marchand; Keli Agama; John L Nitiss; Christophe Redon
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2006

3.  Depletion of topoisomerase IIalpha leads to shortening of the metaphase interkinetochore distance and abnormal persistence of PICH-coated anaphase threads.

Authors:  Jennifer M Spence; Hui Hui Phua; Walter Mills; Adam J Carpenter; Andrew C G Porter; Christine J Farr
Journal:  J Cell Sci       Date:  2007-10-23       Impact factor: 5.285

4.  A constitutive 70 kDa heat-shock protein is localized on the fibres of spindles and asters at metaphase in an ATP-dependent manner: a new chaperone role is proposed.

Authors:  C Agueli; F Geraci; G Giudice; L Chimenti; D Cascino; G Sconzo
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

Review 5.  Mechanism of generation of therapy related leukemia in response to anti-topoisomerase II agents.

Authors:  Ian G Cowell; Caroline A Austin
Journal:  Int J Environ Res Public Health       Date:  2012-05-31       Impact factor: 3.390

6.  An integrative multi-omics analysis based on liquid-liquid phase separation delineates distinct subtypes of lower-grade glioma and identifies a prognostic signature.

Authors:  Jianglin Zheng; Zhipeng Wu; Yue Qiu; Xuan Wang; Xiaobing Jiang
Journal:  J Transl Med       Date:  2022-01-29       Impact factor: 5.531

7.  Rapid exchange of mammalian topoisomerase II alpha at kinetochores and chromosome arms in mitosis.

Authors:  Penny A Tavormina; Marie-George Côme; Joanna R Hudson; Yin-Yuan Mo; William T Beck; Gary J Gorbsky
Journal:  J Cell Biol       Date:  2002-07-08       Impact factor: 10.539

8.  Cell cycle-dependent localization of macroH2A in chromatin of the inactive X chromosome.

Authors:  Brian P Chadwick; Huntington F Willard
Journal:  J Cell Biol       Date:  2002-06-24       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.